Literature DB >> 9669004

Rocuronium is the best non-depolarizing relaxant to prevent succinylcholine fasciculations and myalgia.

R Martin1, J Carrier, M Pirlet, Y Claprood, J P Tétrault.   

Abstract

PURPOSE: To determine which non-depolarizing relaxant among d-tubocurarine, vecuronium, atracurium, mivacurium and rocuronium prevented muscular fasciculations and myalgia following succinylcholine.
METHODS: In this double blind randomized study, 120 female patients scheduled for laparoscopic procedures were studied. They were divided into six groups of 20 according to the non-depolarizing pretreatment used: NaCl 0.9% (control), 0.05 mg.kg-1 d-tubocurarine, 0.01 mg.kg-1 vecuronium, 0.05 mg.kg-1 atracurium, 0.02 mg.kg-1 mivacurium and 0.06 mg.kg-1 rocuronium. Four minutes after the pretreatment, 1.5 mg.kg-1 succinylcholine was injected. Side effects of the pretreatment, the presence and magnitude of fasciculations, the ease of tracheal intubation, myalgia 1, 24 and 48 hr after surgery were observed. A Puritan Bennett Datex 221 NMT Relaxograph monitor was used to evaluate the neuromuscular block.
RESULTS: Muscle fasciculations were observed in 19 of the 20 patients in the control group and in 3 of the 20 patients in the rocuronium group, the best of the pretreatments in that aspect. Four patients in the mivacurium group were unable to sustain more than four seconds head-lift after pretreatment (P < 0.05). Tracheal intubation conditions were better and the onset of block was faster and longer after succinylcholine in the control group (P < 0.05). Myalgias were present in 71% of the patients 24 hr postoperatively and the frequency was not different among the groups.
CONCLUSION: Among the pretreatments tested, 0.06 mg.kg-1 rocuronium was the best to prevent muscular fasciculations following succinylcholine injection. In the population studied, pretreatment did not prevent postoperative myalgia. Succinylcholine 1.5 mg.kg-1 was more effective without a non-depolarizing pretreatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9669004     DOI: 10.1007/BF03012701

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  7 in total

Review 1.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Effect of narcotic pretreatment on pain after rocuronium injection: a randomized, double-blind controlled comparison with lidocaine.

Authors:  Mukta Singh; Himanshu Chauhan; Girija P Rath; Hemanshu Prabhakar; Parmod K Bithal; Hari H Dash
Journal:  J Anesth       Date:  2007-11-01       Impact factor: 2.078

Review 3.  Rocuronium versus succinylcholine for rapid sequence induction intubation.

Authors:  Diem T T Tran; Ethan K Newton; Victoria A H Mount; Jacques S Lee; George A Wells; Jeffrey J Perry
Journal:  Cochrane Database Syst Rev       Date:  2015-10-29

4.  A randomized trial to identify optimal precurarizing dose of rocuronium to avoid precurarization-induced neuromuscular block.

Authors:  Naoko Fukano; Takahiro Suzuki; Kiyoko Ishikawa; Hitoshi Mizutani; Shigeru Saeki; Setsuro Ogawa
Journal:  J Anesth       Date:  2011-01-12       Impact factor: 2.078

5.  Pharmacological interventions for acceleration of the onset time of rocuronium: a meta-analysis.

Authors:  Jing Dong; Lingqi Gao; Wenqing Lu; Zifeng Xu; Jijian Zheng
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

6.  The efficacy of Antipyretic Analgesics administration intravenously for Preventing Rocuronium-Associated Pain/Withdrawal Response: a systematic review and meta-analysis.

Authors:  Jia Wang; Yu Cui; Bin Liu; Jianfeng Chen
Journal:  BMC Anesthesiol       Date:  2020-04-20       Impact factor: 2.217

7.  Optimal precurarizing dose of rocuronium to decrease fasciculation and myalgia following succinylcholine administration.

Authors:  Kyu Nam Kim; Kyo Sang Kim; Hoon Il Choi; Ji Seon Jeong; Hee-Jong Lee
Journal:  Korean J Anesthesiol       Date:  2014-06-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.